Stay updated with breaking news from License Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA issues complete response letters to Regeneron Pharmaceuticals Inc's BLA for odronextamab in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma, requesting more trial data without concerns about efficacy, safety, or design. Regulatory review continues with the EMA.
Monday, the FDA issued complete response letters (CRL) to Regeneron Pharmaceuticals Inc’s REGN Biologics License Application (BLA) for odronextamab in…
A Minnesota board was justified when it rejected a substitute teaching license for a former police officer who fatally shot a Black man during a traffic stop in 2016, an appeals court ruled Monday. The Minnesota Court of Appeals affirmed the findings of the Minnesota Professional Educator Licensing and Standards Board, which concluded Jeronimo Yanez did not meet the moral standards required to teach in public schools. The court had sent the case back to the licensing board in 2022 to reconsider its initial rejection of Yanez's teaching license application, which was based on “imm...
In honor of Rare Disease Day, this exploration of prurigo nodularis highlights the skin disease’s psychosocial impact on patients around the world living with the condition.
On Feb. 2, 2024, the Property & Casualty Insurance Committee of the National Council of Insurance Legislators (NCOIL) adopted a new Public Adjuster Professional Standards Reform Model...